Somatic Expansion and Emerging Therapeutic Targets in Huntington disease

This patient engagement day will provide the Huntingtons disease community with accessible, up-to-date insights into somatic expansion of the Huntingtons disease CAG repeat and its role in disease progression. Attendees will gain an understanding of ongoing observational studies, clinical trials, and emerging therapeutic strategies targeting somatic expansion of the Huntington disease CAG repeat. Through presentations, interactive discussions, and “meet the scientists” sessions, patients, families, and carers will have opportunities to ask questions, clarify misconceptions, and deepen their scientific literacy.

Info: “Meet the HD Scientists” activity (accessible educational materials on Huntington disease, its genetics and somatic expansion)

Info: Dr James Herron,
Consultant Psychiatrist in HD Psychiatry/Research, NHS Greater Glasgow and Clyde; Enroll-HD and HDClarity Principal Investigator in Glasgow

Info: Prof Darren Monckton,
Professor of Human Genetics, University of Glasgow

Info: “Meet the HD Scientists” activity (accessible educational materials on Huntington disease, its genetics and somatic expansion)

Info: Dr Caroline Benn,
Chief Scientific Officer at LoQus23 Therapeutics

Info: Dr Madeleine Wakeling,
Chief Operating Officer at Harness Therapeutics

Info: Dr Mena Farag,
Specialist Registrar in Neurology, King’s College Hospital

Info: “Meet the HD Scientists” activity (accessible educational materials on Huntington disease, its genetics and somatic expansion)

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher University of Glasgow